China Biotech CEO Interview with Hua Medicine’s Li Chen
Citeline Podcasts - A podcast by Citeline
Categories:
Hua Medicine’s founder and CEO Li Chen discusses with host Brian Yang about its new product launch for dorzagliatin, glucokinase activator for type 2 diabetes in China, partnership with Bayer, and plans to get reimbursed through National Reimbursement Drug List. https://scrip.pharmaintelligence.informa.com/SC148981/Hua-Medicines-Chen-On-Product-Launch-Bayer-Partnership-And-Reimbursement